Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled,...

Por Griffin, Kurt J, Thompson, Paul A, Gottschalk, Michael, Kyllo, Jennifer H, Rabinovitch, Alex
Publicado no Lancet Diabetes Endocrinol (2014)

Elimination of Pasteurella pneumotropica from a Mouse Barrier Facility by Using a Modified Enrofloxacin Treatment Regimen

Por Towne, Justin W, Wagner, April M, Griffin, Kurt J, Buntzman, Adam S, Frelinger, Jeffrey A, Besselsen, David G
Publicado em 2014

The Paradoxical Increase in Cortisol Secretion Induced by Dexamethasone in Primary Pigmented Nodular Adrenocortical Disease Involves a Glucocorticoid Receptor-Mediated Effect of De...

Por Louiset, Estelle, Stratakis, Constantine A., Perraudin, Véronique, Griffin, Kurt J., Libé, Rossella, Cabrol, Sylvie, Fève, Bruno, Young, Jacques, Groussin, Lionel, Bertherat, Jérôme, Lefebvre, Hervé
Publicado em 2009

The Paradoxical Increase in Cortisol Secretion Induced by Dexamethasone in Primary Pigmented Nodular Adrenocortical Disease Involves a Glucocorticoid Receptor-Mediated Effect of De...

Por Louiset, Estelle, Stratakis, Constantine A., Perraudin, Véronique, Griffin, Kurt J., Libé, Rossella, Cabrol, Sylvie, Fève, Bruno, Young, Jacques, Groussin, Lionel, Bertherat, Jérôme, Lefebvre, Hervé
Publicado no Mol Endocrinol (2009)

Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53(+/−) or Rb1(+/−) backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle...

Por Almeida, Madson Q., Muchow, Michael, Boikos, Sosipatros, Bauer, Andrew J., Griffin, Kurt J., Tsang, Kit Man, Cheadle, Chris, Watkins, Tonya, Wen, Feng, Starost, Matthew F., Bossis, Ioannis, Nesterova, Maria, Stratakis, Constantine A.
Publicado em 2010

Oral Cysteamine bitartrate and N-acetylcysteine combination for patients with infantile neuronal ceroid lipofuscinosis:a pilot study

Por Levin, Sondra W., Baker, Eva H., Zein, Wadih M., Zhang, Zhongjian, Quezado, Zenaide M.N., Miao, Ning, Gropman, Andrea, Griffin, Kurt J., Bianconi, Simona, Chandra, Goutam, Khan, Omar I., Caruso, Rafael C., Liu, Aiyi, Mukherjee, Anil B.
Publicado em 2014

Targeting effector memory T cells with alefacept in new onset type 1 diabetes: 12 month results from the T1DAL study

Por Rigby, Mark R, DiMeglio, Linda A, Rendell, Marc S, Felner, Eric I, Dostou, Jean M, Gitelman, Stephen E, Patel, Chetanbabu M, Griffin, Kurt J, Tsalikian, Eva, Gottlieb, Peter A, Greenbaum, Carla J, Sherry, Nicole A, Moore, Wayne V, Monzavi, Roshanak, Willi, Steven M, Raskin, Philip, Moran, Antoinette, Russell, William E, Pinckney, Ashley, Keyes-Elstein, Lynette, Howell, Michael, Aggarwal, Sudeepta, Lim, Noha, Phippard, Deborah, Nepom, Gerald T, McNamara, James, Ehlers, Mario R
Publicado em 2013

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

Por Rigby, Mark R., Harris, Kristina M., Pinckney, Ashley, DiMeglio, Linda A., Rendell, Marc S., Felner, Eric I., Dostou, Jean M., Gitelman, Stephen E., Griffin, Kurt J., Tsalikian, Eva, Gottlieb, Peter A., Greenbaum, Carla J., Sherry, Nicole A., Moore, Wayne V., Monzavi, Roshanak, Willi, Steven M., Raskin, Philip, Keyes-Elstein, Lynette, Long, S. Alice, Kanaparthi, Sai, Lim, Noha, Phippard, Deborah, Soppe, Carol L., Fitzgibbon, Margret L., McNamara, James, Nepom, Gerald T., Ehlers, Mario R.
Publicado no J Clin Invest (2015)